Trademark: 97457119
Word
VIRACTA
Status Date
Tuesday, April 9, 2024
Registration Number
7356577
Registration Date
Tuesday, April 9, 2024
Filing Date
Tuesday, June 14, 2022
Published for Opposition
Tuesday, May 30, 2023
5 Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases and disorders; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies; all of the foregoing containing antivirals
44 Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring medical information in the fields of cancer, viral-associated cancers and other viral associated diseases and disorders
42 Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignancies
The mark consists of the stylized word "VIRACTA" with all the elements in teal except for the dot above the "I" which is green.
The color(s) teal and green is/are claimed as a feature of the mark.
Apr 9, 2024
Registered-Principal Register
Apr 9, 2024
Notice Of Registration Confirmation Emailed
Mar 6, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 5, 2024
Allowed Principal Register - Sou Accepted
Feb 5, 2024
Statement Of Use Processing Complete
Jan 16, 2024
Use Amendment Filed
Feb 5, 2024
Case Assigned To Intent To Use Paralegal
Jan 16, 2024
Teas Statement Of Use Received
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 26, 2023
Approved For Pub - Principal Register
Apr 21, 2023
Teas/Email Correspondence Entered
Apr 21, 2023
Correspondence Received In Law Office
Apr 21, 2023
Teas Response To Office Action Received
Apr 3, 2023
Notification Of Non-Final Action E-Mailed
Apr 3, 2023
Non-Final Action E-Mailed
Apr 3, 2023
Non-Final Action Written
Mar 27, 2023
Assigned To Examiner
Jun 27, 2022
New Application Office Supplied Data Entered
Jun 17, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
